2SEVENTY BIO Trademark

Trademark Overview

On Monday, April 26, 2021, a trademark application was filed for 2SEVENTY BIO with the United States Patent and Trademark Office. The USPTO has given the 2SEVENTY BIO trademark a serial number of 90671815. The federal status of this trademark filing is EX PARTE APPEAL PENDING as of Wednesday, November 20, 2024. This trademark is owned by 2seventy bio, Inc.. The 2SEVENTY BIO trademark is filed in the Computer & Software Services & Scientific Services category with the following description:

Pharmaceutical research and development
2seventy bio

General Information

Serial Number90671815
Word Mark2SEVENTY BIO
Filing DateMonday, April 26, 2021
Status760 - EX PARTE APPEAL PENDING
Status DateWednesday, November 20, 2024
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateNOT AVAILABLE

Trademark Statements

Pseudo MarkTWO SEVENTY BIO
NOT AVAILABLE"BIO"
Goods and ServicesPharmaceutical research and development

Classification Information

International Class042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateSaturday, July 31, 2021
Primary Code042
First Use Anywhere DateTuesday, January 31, 2023
First Use In Commerce DateTuesday, January 31, 2023

Trademark Owner History

Party Name2seventy bio, Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressCambridge, MA 02142

Trademark Events

Event DateEvent Description
Thursday, April 29, 2021NEW APPLICATION ENTERED
Saturday, July 31, 2021NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Tuesday, December 21, 2021ASSIGNED TO EXAMINER
Monday, January 3, 2022NON-FINAL ACTION WRITTEN
Monday, January 3, 2022NON-FINAL ACTION E-MAILED
Monday, January 3, 2022NOTIFICATION OF NON-FINAL ACTION E-MAILED
Thursday, June 30, 2022TEAS RESPONSE TO OFFICE ACTION RECEIVED
Thursday, June 30, 2022CORRESPONDENCE RECEIVED IN LAW OFFICE
Thursday, June 30, 2022TEAS/EMAIL CORRESPONDENCE ENTERED
Friday, July 22, 2022SUSPENSION LETTER WRITTEN
Friday, July 22, 2022LETTER OF SUSPENSION E-MAILED
Friday, July 22, 2022NOTIFICATION OF LETTER OF SUSPENSION E-MAILED
Wednesday, February 8, 2023NON-FINAL ACTION WRITTEN
Wednesday, February 8, 2023NON-FINAL ACTION E-MAILED
Wednesday, February 8, 2023NOTIFICATION OF NON-FINAL ACTION E-MAILED
Wednesday, March 1, 2023SUSPENSION CHECKED - TO ATTORNEY FOR ACTION
Tuesday, May 2, 2023APPLICATION EXTENSION TO RESPONSE PERIOD - RECEIVED
Tuesday, May 2, 2023APPLICATION EXTENSION GRANTED/RECEIPT PROVIDED
Tuesday, August 8, 2023TEAS RESPONSE TO OFFICE ACTION RECEIVED
Tuesday, August 8, 2023CORRESPONDENCE RECEIVED IN LAW OFFICE
Tuesday, August 8, 2023TEAS/EMAIL CORRESPONDENCE ENTERED
Tuesday, April 23, 2024FINAL REFUSAL WRITTEN
Tuesday, April 23, 2024NOTIFICATION OF FINAL REFUSAL EMAILED
Tuesday, April 23, 2024FINAL REFUSAL E-MAILED
Friday, July 5, 2024APPLICATION EXTENSION GRANTED/RECEIPT PROVIDED
Friday, July 5, 2024APPLICATION EXTENSION TO RESPONSE PERIOD - RECEIVED
Tuesday, October 15, 2024TEAS AMENDMENT OF USE RECEIVED
Tuesday, October 15, 2024USE AMENDMENT FILED
Tuesday, October 15, 2024AMENDMENT TO USE PROCESSING COMPLETE
Tuesday, October 22, 2024TEAS REQUEST FOR RECONSIDERATION RECEIVED
Tuesday, October 22, 2024EXPARTE APPEAL RECEIVED AT TTAB
Tuesday, October 22, 2024EX PARTE APPEAL-INSTITUTED
Tuesday, October 22, 2024JURISDICTION RESTORED TO EXAMINING ATTORNEY
Tuesday, November 19, 2024ACTION DENYING REQ FOR RECON E-MAILED
Tuesday, November 19, 2024USE AMENDMENT ACCEPTED
Tuesday, November 19, 2024ACTION CONTINUING FINAL - COMPLETED
Tuesday, November 19, 2024NOTIFICATION OF ACTION DENYING REQ FOR RECON E-MAILED

Related Keywords

seventy development research pharmaceutical